These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26239351)

  • 1. Concise Review: Methods and Cell Types Used to Generate Down Syndrome Induced Pluripotent Stem Cells.
    Hibaoui Y; Feki A
    J Clin Med; 2015 Apr; 4(4):696-714. PubMed ID: 26239351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
    M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
    Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data in brief: Transcriptome analysis of induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.
    Hibaoui Y; Grad I; Letourneau A; Santoni FA; Antonarakis SE; Feki A
    Genom Data; 2014 Dec; 2():226-9. PubMed ID: 26484098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
    Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
    Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief report: isogenic induced pluripotent stem cell lines from an adult with mosaic down syndrome model accelerated neuronal ageing and neurodegeneration.
    Murray A; Letourneau A; Canzonetta C; Stathaki E; Gimelli S; Sloan-Bena F; Abrehart R; Goh P; Lim S; Baldo C; Dagna-Bricarelli F; Hannan S; Mortensen M; Ballard D; Syndercombe Court D; Fusaki N; Hasegawa M; Smart TG; Bishop C; Antonarakis SE; Groet J; Nizetic D
    Stem Cells; 2015 Jun; 33(6):2077-84. PubMed ID: 25694335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isogenic pairs of induced-pluripotent stem-derived endothelial cells identify DYRK1A/PPARG/EGR1 pathway is responsible for Down syndrome-associated pulmonary hypertension.
    Suginobe H; Ishida H; Ishii Y; Ueda K; Yoshihara C; Ueyama A; Wang R; Tsuru H; Hashimoto K; Hirose M; Ishii R; Narita J; Kitabatake Y; Ozono K
    Hum Mol Genet; 2023 Dec; 33(1):78-90. PubMed ID: 37792788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of keratinocytic phenotypes in autonomous trisomy-rescued cells.
    Tanuma-Takahashi A; Inoue M; Kajiwara K; Takagi R; Yamaguchi A; Samura O; Akutsu H; Sago H; Kiyono T; Okamoto A; Umezawa A
    Stem Cell Res Ther; 2021 Aug; 12(1):476. PubMed ID: 34433490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dynamic in vitro model of Down syndrome neurogenesis with trisomy 21 gene dosage correction.
    Bansal P; Banda EC; Glatt-Deeley HR; Stoddard CE; Linsley JW; Arora N; Deleschaux C; Ahern DT; Kondaveeti Y; Massey RE; Nicouleau M; Wang S; Sabariego-Navarro M; Dierssen M; Finkbeiner S; Pinter SF
    Sci Adv; 2024 Jun; 10(23):eadj0385. PubMed ID: 38848354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancing Knowledge of Down Syndrome Brain Development and Function With Human Stem Cells.
    Bhattacharyya A
    Am J Intellect Dev Disabil; 2020 Mar; 125(2):90-92. PubMed ID: 32058817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel derivation of X-monosomy induced pluripotent stem cells (iPSCs) with isogenic control iPSCs.
    Feki A; Sloan-Béna F; Hibaoui Y
    Stem Cell Res; 2020 Jul; 47():101920. PubMed ID: 32739879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells.
    Chou ST; Byrska-Bishop M; Tober JM; Yao Y; Vandorn D; Opalinska JB; Mills JA; Choi JK; Speck NA; Gadue P; Hardison RC; Nemiroff RL; French DL; Weiss MJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(43):17573-8. PubMed ID: 23045704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration-free induced pluripotent stem cells model genetic and neural developmental features of down syndrome etiology.
    Briggs JA; Sun J; Shepherd J; Ovchinnikov DA; Chung TL; Nayler SP; Kao LP; Morrow CA; Thakar NY; Soo SY; Peura T; Grimmond S; Wolvetang EJ
    Stem Cells; 2013 Mar; 31(3):467-78. PubMed ID: 23225669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell models for Down syndrome-Alzheimer's disease research.
    Wu Y; West NR; Bhattacharyya A; Wiseman FK
    Neuronal Signal; 2022 Apr; 6(1):NS20210054. PubMed ID: 35449591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells as a cellular model for studying Down Syndrome.
    Brigida AL; Siniscalco D
    J Stem Cells Regen Med; 2016; 12(2):54-60. PubMed ID: 28096629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trisomy correction in Down syndrome induced pluripotent stem cells.
    Li LB; Chang KH; Wang PR; Hirata RK; Papayannopoulou T; Russell DW
    Cell Stem Cell; 2012 Nov; 11(5):615-9. PubMed ID: 23084023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.
    Rohani L; Johnson AA; Naghsh P; Rancourt DE; Ulrich H; Holland H
    Stem Cells Transl Med; 2018 Dec; 7(12):867-875. PubMed ID: 30218497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
    Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Annerén G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
    Mol Neurobiol; 2019 Oct; 56(10):7113-7127. PubMed ID: 30989628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
    Çağlayan ES
    Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling.
    Moon JE; Lawrence JB
    Cell Rep; 2022 Aug; 40(6):111174. PubMed ID: 35947952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The spontaneous differentiation and chromosome loss in iPSCs of human trisomy 18 syndrome.
    Li T; Zhao H; Han X; Yao J; Zhang L; Guo Y; Shao Z; Jin Y; Lai D
    Cell Death Dis; 2017 Oct; 8(10):e3149. PubMed ID: 29072700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.